首页> 美国卫生研究院文献>Nucleic Acids Research >Lnc2Cancer v2.0: updated database of experimentally supported long non-coding RNAs in human cancers
【2h】

Lnc2Cancer v2.0: updated database of experimentally supported long non-coding RNAs in human cancers

机译:Lnc2Cancer v2.0:更新了人类癌症中实验支持的长非编码RNA的更新数据库

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Lnc2Cancer 2.0 () is an updated database that provides comprehensive experimentally supported associations between lncRNAs and human cancers. In Lnc2Cancer 2.0, we have updated the database with more data and several new features, including (i) exceeding a 4-fold increase over the previous version, recruiting 4989 lncRNA-cancer associations between 1614 lncRNAs and 165 cancer subtypes. (ii) newly adding about 800 experimentally supported circulating, drug-resistant and prognostic-related lncRNAs in various cancers. (iii) appending the regulatory mechanism of lncRNA in cancer, including microRNA (miRNA), transcription factor (TF), variant and methylation regulation. (iv) increasing more than 70 high-throughput experiments (microarray and next-generation sequencing) of lncRNAs in cancers. (v) Scoring the associations between lncRNA and cancer to evaluate the correlations. (vi) updating the annotation information of lncRNAs (version 28) and containing more detailed descriptions for lncRNAs and cancers. Moreover, a newly designed, user-friendly interface was also developed to provide a convenient platform for users. In particular, the functions of browsing data by cancer primary organ, biomarker type and regulatory mechanism, advanced search following several features and filtering the data by LncRNA-Cancer score were enhanced. Lnc2Cancer 2.0 will be a useful resource platform for further understanding the associations between lncRNA and human cancer.
机译:Lnc2Cancer 2.0()是一个更新的数据库,可提供lncRNA与人类癌症之间全面的实验支持关联。在Lnc2Cancer 2.0中,我们用更多数据和几个新功能更新了数据库,其中包括(i)比以前的版本增加4倍,在1614个lncRNA和165种癌症亚型之间招募了4989个lncRNA-癌症关联。 (ii)在各种癌症中新添加了约800个实验支持的循环型,耐药性和预后相关的lncRNA。 (iii)附加lncRNA在癌症中的调控机制,包括microRNA(miRNA),转录因子(TF),变体和甲基化调控。 (iv)增加70多个lncRNA在癌症中的高通量实验(微阵列和下一代测序)。 (v)对lncRNA与癌症之间的关联进行评分以评估相关性。 (vi)更新lncRNA的注释信息(版本28),并包含有关lncRNA和癌症的更详细描述。此外,还开发了新设计的用户友好界面,为用户提供了方便的平台。特别是,增强了按癌症原发器官浏览数据,生物标记物类型和调控机制,遵循若干功能的高级搜索以及按LncRNA-Cancer分数过滤数据的功能。 Lnc2Cancer 2.0将成为进一步了解lncRNA与人类癌症之间联系的有用资源平台。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号